Kinase Test May Yield Big Gains for Drug-Resistant Cancers

December 05, 2020

A UNC research team, led by Gary Johnson, PhD, has developed a test that can measure both the presence and activity of 60-70 percent of all kinases simultaneously, allowing investigators to see how cancers evade treatment with kinase inhibitors so that they can combine drugs to block resistance. Read more at